Role of combinations of polymorphisms of cytokine genes in the diagnosis of Legg–Calve–Perthes disease in children

Abstract

Background. Legg–Calve–Perthes disease (LCPD) is an idiopathic avascular femoral head osteonecrosis. The early disease stage is associated with the development of synovitis of the hip joint linked to the overproduction of factors induced by hypoxia as well as of interleukin (IL)-6. Associations of individual polymorphic variants of cytokine genes with LCPD have been shown. Moreover, alterations in the cytokine regulatory cascade are considered an important link in the pathogenesis of synovial inflammation in the early stages of LCPD. Accordingly, this process may be associated with a certain combination of polymorphic variants of the genes for pro-inflammatory and anti-inflammatory cytokines.

Aim. This study aimed to study the associations of polymorphic variants of the genes for pro-inflammatory and anti-inflammatory IL with LCPD.

Materials and methods. In this case–control study, the main and control groups were composed of 26 children with LCPD and 40 healthy children (all aged 3–11 years), respectively. Genotyping of IL10 (rs1800896), IL13 (rs20541), IL18 (rs187238), IL18 (rs5744292), IL1a (rs1800587), IL1RA (POL_GF_58), IL-1Ra (rs4251961), IL1B (rs16944), IL1B (rs1143634), IL4 (POL_GF_59), IL4 (rs2243250), IL6 (rs1800796), IL6 (rs1800795), INFγ (rs2430561), TGFβ (rs1800469), and TNF (rs1800629) was performed by polymerase chain reaction (PCR) using TaqMan probes to the corresponding polymorphic variants of genes produced by Thermo Fisher Scientific (USA) on an amplifier ViiATM 7 RealTime PCR System (Life Technologies, USA). Statistical processing of the results was carried out using the SNPstats program and multifactor dimensionality reduction.

Results. The study revealed three separate LCPD-potentiating genotypes of polymorphic variants of cytokine genes: IL10 (rs1800896; T>C)*T/C (OR 6.50), IL4 (POL_GF_49, VNTR, Intron4)*2R/2R (OR 12.32), and IL-6 (rs1800796; G>C)*G/C (OR 4.08). Two polymorphic variants of the IL4 gene (POL_GF_49, VNTR, Intron4, and rs2243250; C>T) had a pronounced synergism with respect to the diagnosis of LCPD. Moderate synergy with respect to the diagnosis of LCPD demonstrated the intergenic interaction of IL6 (rs1800796, G>C) with tumor necrosis factor-α (rs1800629, G>A). Moderate antagonism between LCPD and intergenic interactions was obtained for polymorphic variants of IL18 (rs5744292, T>C) and transforming growth factor-β (rs1800469, A>G) genes.

Conclusions. The pathogenesis of synovitis and subsequent osteonecrosis in LCPD is associated with a combination of polymorphic variants of the genes of pro-inflammatory and anti-inflammatory cytokines, as well as of DNA variants of the pro-allergic IL4 gene.

Keywords

Legg-Calve-Perthes disease / polymorphic gene variants / IL10 (rs1800896) / IL4 (POL_GF_49) / IL6 (rs1800795)

References

[1] Srzentic S, Spasovski V, Spasovski D, et al. Association of gene variants in TLR4 and IL-6 genes with Perthes disease. Srpski arhiv za celokupno lekarstvo. 2014;142(7-8):450-456. https://doi.org/ 10.2298/sarh1408450s.

[2] Тепленький М.П., Чепелева М.В., Кузнецова Е.И. Болезнь Пертеса: иммунологические аспекты // Клиническая лабораторная диагностика. – 2020. – Т. 65. – № 4. – С. 239–243. [Teplen’kiy MP, Chepeleva MV, Kuznetsova EI. Perthes Disease: Immunological Aspects. Russian Clinical Laboratory Diagnostics. 2020;65(4):239-243. (In Russ.)]. https://doi.org/10.18821/0869-2084-2020-65-4-239-243.

[3] van Wijnen A, Adapala NS, Kim HKW. Comprehensive genome-wide transcriptomic analysis of immature articular cartilage following ischemic osteonecrosis of the femoral head in piglets. PLOS One. 2016;11(4):e0153174. https://doi.org/10.1371/journal.pone.0153174.

[4] Kim KM, Wagle S, Moon YJ, et al. Interferon β protects against avascular osteonecrosis through interleukin 6 inhibition and silent information regulator transcript-1 upregulation. Oncotarget. 2017;9(3):3562-3575. https://doi.org/10.18632/oncotarget.23337.

[5] Adapala NS, Yamaguchi R, Phipps M, et al. Necrotic bone stimulates proinflammatory responses in macrophages through the activation of Toll-like receptor 4. Am J Pathol. 2016;186(11):2987-2999. https://doi.org/10.1016/j.ajpath.2016.06.024.

[6] Azarpira MR, Ghilian MM, Sobhan MR, et al. Association of eNOS 27-bp VNTR, 894G>T and 786T>C polymorphisms with susceptibility to Legg-Calve-Perthes disease in Iranian children. J Orthop. 2019;16(2):137-140. https://doi.org/10.1016/j.jor.2019. 02.024.

[7] Azarpira MR, Ghilian MM, Sobhan MR, et al. Association of MTHFR and TNF-alpha genes polymorphisms with susceptibility to Legg-Calve-Perthes disease in Iranian children: A case-control study. J Orthop. 2018;15(4):984-987. https://doi.org/10.1016/j.jor.2018. 08.042.

[8] Yamaguchi R, Kamiya N, Adapala NS, et al. HIF-1-dependent IL-6 activation in articular chondrocytes initiating synovitis in femoral head ischemic osteonecrosis. J Bone Joint Surg Am. 2016;98(13):1122-1131. https://doi.org/10.2106/JBJS.15.01209.

[9] Kim HK. Pathophysiology and new strategies for the treatment of Legg-Calve-Perthes disease. J Bone Joint Surg Am. 2012;94(7):659-669. https://doi.org/10.2106/JBJS.J.01834.

[10] Kim HK, Morgan-Bagley S, Kostenuik P. RANKL inhibition: A novel strategy to decrease femoral head deformity after ischemic osteonecrosis. J Bone Miner Res. 2006;21(12):1946-1954. https://doi.org/10.1359/jbmr.060905.

[11] Kuroyanagi G, Adapala NS, Yamaguchi R, et al. Interleukin-6 deletion stimulates revascularization and new bone formation following ischemic osteonecrosis in a murine model. Bone. 2018;116:221-231. https://doi.org/10.1016/j.bone.2018.08.011.

[12] Wang AH, Lam WJ, Han DY, et al. The effect of IL-10 genetic variation and interleukin 10 serum levels on Crohn’s disease susceptibility in a New Zealand population. Hum Immunol. 2011;72(5):431-435. https://doi.org/10.1016/j.humimm.2011.02.014.

[13] Fiorentino DF, Zlotnik A, Mosmann TR, et al. IL-10 inhibits cytokine production by activated macrophages. J Immunol. 1991;147(11):3815-3822.

[14] Fernandes MT, Fernandes KB, Marquez AS, et al. Association of interleukin-6 gene polymorphism (rs1800796) with severity and functional status of osteoarthritis in elderly individuals. Cytokine. 2015;75(2):316-320. https://doi.org/10.1016/j.cyto.2015.07.020.

[15] Akbarian-Bafghi MJ, Dastgheib SA, Morovati-Sharifabad M, et al. Association of IL-6 -174G > C and -572G > C polymorphisms with risk of Legg-Calve-Perthes disease in Iranian children. Fetal Pediatr Pathol. 2019:1-8. https://doi.org/10.1080/15513815.2019.1693671.

[16] Amr K, El-Awady R, Raslan H. Assessment of the -174G/C (rs1800795) and -572G/C (rs1800796) interleukin 6 gene polymorphisms in Egyptian patients with rheumatoid arthritis. Open Access Maced J Med Sci. 2016;4(4):574-577. https://doi.org/10.3889/oamjms.2016.110.

[17] Li J, Lin LH, Wang J, et al. Interleukin-4 and interleukin-13 pathway genetics affect disease susceptibility, serum immunoglobulin E levels, and gene expression in asthma. Ann Allergy Asthma Immunol. 2014;113(2):173-179 e171. https://doi.org/10.1016/j.anai. 2014.05.004.

[18] Liu S, Li T, Liu J. Interleukin-4 rs2243250 polymorphism is associated with asthma among Caucasians and related to atopic asthma. Cytokine. 2012;59(2):364-369. https://doi.org/10.1016/j.cyto.2012.05.006.

[19] Al-Eitan LN, Rababa’h DM, Alghamdi MA, Khasawneh RH. The influence of an IL-4 variable number tandem repeat (VNTR) polymorphism on breast cancer susceptibility. Pharmgenomics Pers Med. 2019;12:201-207. https://doi.org/10.2147/PGPM.S220571.

[20] Dziedziejko V, Kurzawski M, Paczkowska E, et al. The impact of IL18 gene polymorphisms on mRNA levels and interleukin-18 release by peripheral blood mononuclear cells. Postepy Hig Med Dosw (Online). 2012;66: 409-414. https://doi.org/10.5604/17322693.1000980.

[21] Harsanyi S, Zamborsky R, Krajciova L, et al. Developmental dysplasia of the hip: A review of etiopathogenesis, risk factors, and genetic aspects. Medicina (Kaunas). 2020;56(4). https://doi.org/10.3390/medicina56040153.

RIGHTS & PERMISSIONS

Shabaldin N.A., Shabaldin A.V., Apalko S.V., Tsepokina A.V., Rovda Y.I.